Skip to main content
Veterinary Medicines

Intubeaze 20 mg/ml laryngopharyngeal spray, solution for cats

Authorised
  • Lidocaine hydrochloride monohydrate

Product identification

Medicine name:
Intubeaze 20 mg/ml laryngopharyngeal spray, solution for cats
Intubeaze 20 mg/ml laryngofaryngeaal spray, oplossing voor katten
Active substance:
  • Lidocaine hydrochloride monohydrate
Target species:
  • Cat
Route of administration:
  • Laryngopharyngeal use

Product details

Active substance and strength:
  • Lidocaine hydrochloride monohydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Laryngopharyngeal spray, solution
Withdrawal period by route of administration:
  • Laryngopharyngeal use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR02AD02
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • A clear, colourless Type I glass vial with a polypropylene and polyethylene spray pump and actuator containing 10 ml. Vial packaged in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 122015
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0554/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/01/2022

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."